50 Result(s)

Article

Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWP

Adult T-cell leukemia/lymphoma (ATL) carries a dismal prognosis. Experience with allo-SCT for ATL appears encouraging but is limited to Japanese series. This retrospective analysis of the EBMT registry reveale...

A Bazarbachi, K Cwynarski, A Boumendil, H Finel, P Fields… in Bone Marrow Transplantation (2014)

Article

Comparison of upfront tandem autologous–allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma

We performed a retrospective analysis of the European Group for Blood and Marrow Transplantation database comparing the outcomes of multiple myeloma patients who received tandem autologous followed by allogene...

F Sahebi, S Iacobelli, A V Biezen, L Volin, P Dreger… in Bone Marrow Transplantation (2015)

Article

Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT Lymphoma Working Party

The aim of this registry-based retrospective study was to analyze the outcome of second allogeneic hematopoietic SCT (alloHSCT_2) performed in patients with lymphoma who had relapsed after a first allogeneic t...

K Horstmann, A Boumendil, J Finke, H Finel, E Kanfer… in Bone Marrow Transplantation (2015)

Article

Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

This is the sixth special report that the European Society for Blood and Marrow Transplantation regularly publishes on the current practice and indications for haematopoietic SCT for haematological diseases, s...

A Sureda, P Bader, S Cesaro, P Dreger, R F Duarte, C Dufour… in Bone Marrow Transplantation (2015)

Article

Allogeneic hematopoietic stem cell transplantation for poor-risk CLL: dissecting immune-modulating strategies for disease eradication and treatment of relapse

To elucidate factors contributing to the effectiveness of allogeneic hematopoietic stem cell transplantation (alloHCT) in high-risk CLL, immune interventions, GvHD and clinical outcome of 77 consecutive patien...

M Hahn, S Böttcher, S Dietrich, U Hegenbart, M Rieger… in Bone Marrow Transplantation (2015)

Article

Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT

In patients treated with allogeneic stem cell transplantation (SCT) for malignant disease who suffer from a relapse after the transplantation, the role of second allogeneic SCT is often uncertain. In a retrosp...

T Ruutu, L C de Wreede, A van Biezen, R Brand, M Mohty… in Bone Marrow Transplantation (2015)

Article

Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT

Clinical information about thiotepa-based autologous stem cell transplantation (auto-SCT) outside the primary central nervous system lymphoma (PCNSL) field is sparse. In this registry-based retrospective study...

L Sellner, A Boumendil, H Finel, S Choquet, G de Rosa… in Bone Marrow Transplantation (2016)

Article

Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes

Limited therapeutic options are available after relapse of acute leukaemia following first reduced intensity conditioning haematopoietic stem cell transplantation (RIC1). A retrospective study on European Soci...

R Vrhovac, M Labopin, F Ciceri, J Finke, E Holler, J Tischer… in Bone Marrow Transplantation (2016)

Article

Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party

Little is known about the prognostic impact of prior paclitaxel therapy and response to induction chemotherapy defined as the regimen preceding high-dose chemotherapy (HDCT) for the salvage therapy of advanced...

A Necchi, R Miceli, M Bregni, C Bokemeyer, L A Berger… in Bone Marrow Transplantation (2016)

Article

Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party

In the era of chemoimmunotherapy, the optimal treatment paradigm for relapsed and refractory diffuse large B-cell lymphoma has been challenged. We reviewed the outcome of standard salvage therapy with an autol...

S P Robinson, A Boumendil, H Finel, D Blaise, X Poiré… in Bone Marrow Transplantation (2016)

Article

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas

Allogeneic hematopoietic cell transplantation (HCT) offers the chance of cure for patients with non-transformed follicular lymphoma (FL), but is associated with the risk of non-relapse mortality (NRM). The aim...

F Heinzelmann, W Bethge, D W Beelen, M Engelhard, N Kröger… in Bone Marrow Transplantation (2016)

Article

Transplantation in CLL: what we can learn from a dinosaur

P Dreger, E Montserrat in Bone Marrow Transplantation (2016)

Article

Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT)

Hematopoietic stem cell transplantation (HSCT) is used with increasing frequency in Europe with 40 000 transplants reported in 2014. Transplant-related mortality remains high in allogeneic HSCT (10–20%); high-...

J R Passweg, H Baldomero, P Bader, C Bonini, S Cesaro… in Bone Marrow Transplantation (2017)

Article

Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation

Even with the availability of targeted drugs, allogeneic hematopoietic cell transplantation (allo-HCT) is the only therapy with curative potential for patients with CLL. Cure can be assessed by comparing long-...

M van Gelder, L C de Wreede, M Bornhäuser, D Niederwieser… in Bone Marrow Transplantation (2017)

Article

Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience

J Meissner, H Finel, S Dietrich, A Boumendil, E Kanfer… in Bone Marrow Transplantation (2017)

Article

GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses

Allogeneic stem cell transplantation (alloSCT) is used for treating patients with T-prolymphocytic leukemia (T-PLL). However, direct evidence of GvL activity in T-PLL is lacking. We correlated minimal residual...

L Sellner, M Brüggemann, M Schlitt, H Knecht, D Herrmann… in Bone Marrow Transplantation (2017)